Revolution Medicines (RVMDW) Other Non Operating Income (2024 - 2026)

Revolution Medicines' Other Non Operating Income history runs 3 years deep, the most recent figure standing at $117000.0 for Q1 2026.

• In Q1 2026, Other Non Operating Income rose 1270.0% year-over-year to $117000.0; the TTM figure through Mar 2026 stood at $58.3 million (up 2410.67% YoY), while the FY2025 annual figure was $58.1 million, changed N/A from the prior year.
• Other Non Operating Income for Q1 2026 stood at $117000.0, down from $58.1 million in the prior quarter.
• The five-year high for Other Non Operating Income was $58.1 million in Q4 2025, with the low at -$2.8 million in Q1 2024.
• The 3-year median for Other Non Operating Income is $66500.0 (2024), against an average of $9.3 million.
• The sharpest annual moves came in 2025 and 2026: Other Non Operating Income soared 99.64% in 2025, then soared 1270.0% in 2026.
• Revolution Medicines' Other Non Operating Income stood at $282000.0 in 2024, then surged by 20518.79% to $58.1 million in 2025, then slumped by 99.8% to $117000.0 in 2026.
• Business Quant data shows RVMDW's Other Non Operating Income at $117000.0 in Q1 2026, $58.1 million in Q4 2025, and -$10000.0 in Q1 2025.